Score Overview
Explore the 2021 public Archive ranking →
Where Myriad Genetics Inc has ranked, year by year
Showing 20 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- MYGN
2017: 33.2% · 2021: 59.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 4.23 | — |
1 Year2025-09-29 | $ 7.24 | -41.53% |
5 Years2021-09-29 | $ 32.22 | -86.87% |
10 Years2016-09-29 | $ 20.70 | -79.57% |
20 Years2006-09-29 | $ 10.63 | -60.22% |
30 Years1996-09-27 | $ 5.45 | -22.33% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 4.23 | $ 7.24 | $ 32.22 | $ 20.70 | $ 10.63 | $ 5.45 |
| Return | — | -41.53% | -86.87% | -79.57% | -60.22% | -22.33% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 806M | -$ 112M | $ 115M |
| 2025 | $ 824M | -$ 365M | $ 149M |
| 2024 | $ 837M | -$ 127M | $ 102M |
| 2023 | $ 753M | -$ 263M | $ 140M |
| 2022 | $ 678M | -$ 112M | $ 114M |
| 2021 | $ 690M | -$ 27M | $ 339M |
| 2020 | $ 557M | -$ 223M | $ 150M |
| 2019 | $ 851M | $ 4M | $ 136M |
| 2018 | $ 772M | $ 131M | $ 180M |
| 2017 | $ 771M | $ 21M | $ 150M |
| 2016 | $ 753M | $ 125M | $ 159M |
| 2015 | $ 723M | $ 80M | $ 144M |
| 2014 | $ 778M | $ 176M | $ 270M |
| 2013 | $ 613M | $ 147M | $ 531M |
| 2012 | $ 496M | $ 112M | $ 454M |
| 2011 | $ 402M | $ 100M | $ 346M |
| 2010 | $ 362M | $ 152M | $ 403M |
| 2009 | $ 326M | $ 84M | $ 316M |
| 2008 | $ 333M | $ 47M | $ 328M |
| 2007 | $ 157M | -$ 34M | $ 308M |
| 2006 | $ 114M | -$ 38M | $ 227M |
| 2005 | $ 82M | -$ 39M | $ 113M |
| 2004 | $ 56M | -$ 40M | $ 115M |
| 2003 | $ 64M | -$ 24M | $ 72M |
| 2002 | $ 53M | -$ 13M | $ 73M |
| 2001 | $ 45M | -$ 7M | $ 127M |
| 2000 | $ 34M | -$ 8M | $ 80M |
| 1999 | $ 25M | -$ 10M | $ 9M |
| 1998 | $ 23M | -$ 9M | $ 14M |
| 1997 | $ 15M | -$ 9M | $ 15M |
| IPO1995 | $ 6M | -$ 5M | $ 13M |
Myriad Genetics Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 82M to $ 824M and net income went from -$ 39M to -$ 365M. Revenue increased in 14 of those 20 years; net income in 12.
Across Myriad Genetics Inc's full reported history, from 1995 to 2025, revenue grew from $ 6M to $ 824M and net income went from -$ 5M to -$ 365M. Revenue increased in 77% of the years measured; net income in 53%.
Myriad Genetics Inc currently holds a 20-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Membership
Continue MYGN’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
